Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Out of sight, out of mind: a prospective observational study to estimate the duration of the Hawthorne effect on hand hygiene events.

Vaisman A, Bannerman G, Matelski J, Tinckam K, Hota SS.

BMJ Qual Saf. 2020 Mar 9. pii: bmjqs-2019-010310. doi: 10.1136/bmjqs-2019-010310. [Epub ahead of print]

PMID:
32152090
2.

Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.

Sapir-Pichhadze R, Zhang X, Ferradji A, Madbouly A, Tinckam KJ, Gebel HM, Blum D, Marrari M, Kim SJ, Fingerson S, Bashyal P, Cardinal H, Foster BJ.

Kidney Int. 2020 Apr;97(4):778-785. doi: 10.1016/j.kint.2019.10.028. Epub 2019 Nov 12.

PMID:
32059998
3.

Intragraft donor-specific antibodies and lung transplantation.

Tikkanen JM, Tinckam K.

Eur Respir J. 2019 Nov 7;54(5). pii: 1901937. doi: 10.1183/13993003.01937-2019. Print 2019 Nov. No abstract available.

PMID:
31699784
4.

Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff.

McCaughan J, Xu Q, Tinckam K.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):37-52. doi: 10.21037/hbsn.2019.01.01. Review.

5.

Measuring alloantibodies: a matter of quantity and quality.

Kiernan JJ, Ellison CA, Tinckam KJ.

Curr Opin Organ Transplant. 2019 Feb;24(1):20-30. doi: 10.1097/MOT.0000000000000593. Review.

PMID:
30507703
6.

De novo donor-specific HLA antibodies in heart transplantation: Do transient de novo DSA confer the same risk as persistent de novo DSA?

Moayedi Y, Fan CS, Tinckam KJ, Ross HJ, McCaughan JA.

Clin Transplant. 2018 Nov;32(11):e13416. doi: 10.1111/ctr.13416. Epub 2018 Oct 22.

PMID:
30276870
7.

Systemic immunosuppression in limbal stem cell transplantation: best practices and future challenges.

Ballios BG, Weisbrod M, Chan CC, Borovik A, Schiff JR, Tinckam KJ, Humar A, Kim SJ, Cole EH, Slomovic AR.

Can J Ophthalmol. 2018 Aug;53(4):314-323. doi: 10.1016/j.jcjo.2017.10.040. Epub 2018 Jan 20. Review.

PMID:
30119783
8.

Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.

McCaughan JA, Tinckam KJ.

Transpl Int. 2018 Oct;31(10):1059-1070. doi: 10.1111/tri.13324. Review.

9.

Another piece of the antibody puzzle: Observations from the HALT study.

Snyder LD, Tinckam KJ.

Am J Transplant. 2018 Sep;18(9):2111-2112. doi: 10.1111/ajt.14959. Epub 2018 Jun 15. No abstract available.

10.

Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation.

McCaughan JA, Battle RK, Singh SKS, Tikkanen JM, Moayedi Y, Ross HJ, Singer LG, Keshavjee S, Tinckam KJ.

Am J Transplant. 2018 Dec;18(12):2924-2933. doi: 10.1111/ajt.14951. Epub 2018 Jun 22.

11.

Comprehensive outcomes after lung retransplantation: A single-center review.

Halloran K, Aversa M, Tinckam K, Martinu T, Binnie M, Chaparro C, Chow CW, Waddell T, McRae K, Pierre A, de Perrot M, Yasufuku K, Cypel M, Keshavjee S, Singer LG.

Clin Transplant. 2018 Jun;32(6):e13281. doi: 10.1111/ctr.13281. Epub 2018 Jun 3.

PMID:
29754418
12.

Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.

Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P.

Am J Transplant. 2018 Jul;18(7):1604-1614. doi: 10.1111/ajt.14752. Epub 2018 May 22.

13.

Peri-operative desensitization for highly sensitized heart transplant patients.

Alhussein M, Moayedi Y, Posada JD, Tinckam K, Ross HJ.

J Heart Lung Transplant. 2018 May;37(5):667-670. doi: 10.1016/j.healun.2017.12.005. Epub 2017 Dec 7. No abstract available.

PMID:
29275140
14.

Clinical Utility of Complement Dependent Assays in Kidney Transplantation.

Lan JH, Tinckam K.

Transplantation. 2018 Jan;102(1S Suppl 1):S14-S22. doi: 10.1097/TP.0000000000001819. Review.

PMID:
29266058
15.

Reciprocity to Increase Participation of Compatible Living Donor and Recipient Pairs in Kidney Paired Donation.

Gill JS, Tinckam K, Fortin MC, Rose C, Shick-Makaroff K, Young K, Lesage J, Cole EH, Toews M, Landsberg DN, Gill J.

Am J Transplant. 2017 Jul;17(7):1723-1728. doi: 10.1111/ajt.14275. Epub 2017 Apr 22.

16.

Sensitization assessment before kidney transplantation.

Reynolds BC, Tinckam KJ.

Transplant Rev (Orlando). 2017 Jan;31(1):18-28. doi: 10.1016/j.trre.2016.10.001. Epub 2016 Oct 8. Review.

PMID:
27836384
17.

Donor-Specific Antibody Monitoring: Where Is the Beef?

Ma J, Patel A, Tinckam K.

Adv Chronic Kidney Dis. 2016 Sep;23(5):317-325. doi: 10.1053/j.ackd.2016.08.004. Review.

PMID:
27742387
18.

De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.

Tikkanen JM, Singer LG, Kim SJ, Li Y, Binnie M, Chaparro C, Chow CW, Martinu T, Azad S, Keshavjee S, Tinckam K.

Am J Respir Crit Care Med. 2016 Sep 1;194(5):596-606. doi: 10.1164/rccm.201509-1857OC.

PMID:
26967790
19.

Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation.

Chruscinski A, Huang FY, Nguyen A, Lioe J, Tumiati LC, Kozuszko S, Tinckam KJ, Rao V, Dunn SE, Persinger MA, Levy GA, Ross HJ.

PLoS One. 2016 Mar 11;11(3):e0151224. doi: 10.1371/journal.pone.0151224. eCollection 2016.

20.

Extracorporeal photopheresis in solid organ transplant-associated acute graft-versus-host disease.

Houston BL, Yan M, Tinckam K, Kamel-Reid S, Chang H, Kuo KH, Tsien C, Seftel MD, Avitzur Y, Grant D, Cserti-Gazdewich CM.

Transfusion. 2016 Apr;56(4):962-9. doi: 10.1111/trf.13467. Epub 2016 Feb 18.

PMID:
26892365
21.

Re-Examining Risk of Repeated HLA Mismatch in Kidney Transplantation.

Tinckam KJ, Rose C, Hariharan S, Gill J.

J Am Soc Nephrol. 2016 Sep;27(9):2833-41. doi: 10.1681/ASN.2015060626. Epub 2016 Feb 17.

22.

Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.

Sapir-Pichhadze R, Pintilie M, Tinckam KJ, Laupacis A, Logan AG, Beyene J, Kim SJ.

Am J Transplant. 2016 Jul;16(7):1958-66. doi: 10.1111/ajt.13717. Epub 2016 Mar 3. Review.

23.

Canadian Forum on Combined Organ Transplantation.

Cantarovich M, Blydt-Hansen TD, Gill J, Tinckam K, Schiff J, Alwayn I, Bain V, Dipchand AI, Isaac D, Kim SJ, Lien D, Zaltzman J, Young K, Nickerson P.

Transplantation. 2016 Jun;100(6):1339-48. doi: 10.1097/TP.0000000000000963.

PMID:
26588007
24.

Organ Donation and Transplantation: The View From Canada.

Knoll GA, Tinckam KJ.

Transplantation. 2015 Nov;99(11):2231-3. doi: 10.1097/TP.0000000000000919. No abstract available.

PMID:
26492047
25.

Kidney Paired Donation Protocol for Participating Donors 2014.

Richardson R, Connelly M, Dipchand C, Garg AX, Ghanekar A, Houde I, Johnston O, Mainra R, McCarrell R, Mueller T, Nickerson P, Pippy C, Storsley L, Tinckam K, Wright L, Yilmaz S, Landsberg D; Protocols Working Group of the Canadian Blood Services’ Living Donation Advisory Committee.

Transplantation. 2015 Oct;99(10 Suppl 1):S1-S88. doi: 10.1097/TP.0000000000000918. No abstract available.

PMID:
26425842
26.

High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms.

Duquesnoy RJ, Gebel HM, Woodle ES, Nickerson P, Baxter-Lowe LA, Bray RA, Claas FH, Eckels DD, Friedewald JJ, Fuggle SV, Gerlach JA, Fung JJ, Kamoun M, Middleton D, Shapiro R, Tambur AR, Taylor CJ, Tinckam K, Zeevi A.

Am J Transplant. 2015 Oct;15(10):2780-1. doi: 10.1111/ajt.13376. Epub 2015 Jul 14. No abstract available.

27.

cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.

Tinckam KJ, Liwski R, Pochinco D, Mousseau M, Grattan A, Nickerson P, Campbell P.

Am J Transplant. 2015 Dec;15(12):3194-201. doi: 10.1111/ajt.13355. Epub 2015 Jun 16.

28.

Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates.

Sapir-Pichhadze R, Tinckam KJ, Laupacis A, Logan AG, Beyene J, Kim SJ.

J Am Soc Nephrol. 2016 Feb;27(2):570-8. doi: 10.1681/ASN.2014090894. Epub 2015 Jun 8.

29.

Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW, Wiebe C, Tinckam K, Bunnapradist S, Samaniego-Picota M, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS; Clinical Trials in Organ Transplantation-09 Consortium.

J Am Soc Nephrol. 2015 Dec;26(12):3114-22. doi: 10.1681/ASN.2014121234. Epub 2015 Apr 29.

30.

Utility of HLA Antibody Testing in Kidney Transplantation.

Konvalinka A, Tinckam K.

J Am Soc Nephrol. 2015 Jul;26(7):1489-502. doi: 10.1681/ASN.2014080837. Epub 2015 Mar 24. Review.

31.

Development and Impact of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients.

Chen CK, Manlhiot C, Conway J, Allain-Rooney T, McCrindle BW, Tinckam K, Dipchand AI.

Am J Transplant. 2015 Aug;15(8):2215-22. doi: 10.1111/ajt.13259. Epub 2015 Mar 17.

32.

C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.

Luk A, Alba AC, Butany J, Tinckam K, Delgado D, Ross HJ.

Transpl Int. 2015 Jul;28(7):857-63. doi: 10.1111/tri.12560. Epub 2015 Mar 27.

33.

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?

Duquesnoy RJ, Kamoun M, Baxter-Lowe LA, Woodle ES, Bray RA, Claas FH, Eckels DD, Friedewald JJ, Fuggle SV, Gebel HM, Gerlach JA, Fung JJ, Middleton D, Nickerson P, Shapiro R, Tambur AR, Taylor CJ, Tinckam K, Zeevi A.

Am J Transplant. 2015 Apr;15(4):923-30. doi: 10.1111/ajt.13167. Epub 2015 Mar 16.

34.

Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.

Alba AC, Tinckam K, Foroutan F, Nelson LM, Gustafsson F, Sander K, Bruunsgaard H, Chih S, Hayes H, Rao V, Delgado D, Ross HJ.

J Heart Lung Transplant. 2015 May;34(5):685-92. doi: 10.1016/j.healun.2014.11.024. Epub 2014 Dec 8.

PMID:
25638296
35.

Survival in sensitized lung transplant recipients with perioperative desensitization.

Tinckam KJ, Keshavjee S, Chaparro C, Barth D, Azad S, Binnie M, Chow CW, de Perrot M, Pierre AF, Waddell TK, Yasufuku K, Cypel M, Singer LG.

Am J Transplant. 2015 Feb;15(2):417-26. doi: 10.1111/ajt.13076.

36.

HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.

Sapir-Pichhadze R, Tinckam K, Quach K, Logan AG, Laupacis A, John R, Beyene J, Kim SJ.

Am J Transplant. 2015 Jan;15(1):137-48. doi: 10.1111/ajt.12968. Epub 2014 Dec 17.

37.

Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection.

Remport A, Ivanyi B, Mathe Z, Tinckam K, Mucsi I, Molnar MZ.

Nephrol Dial Transplant. 2015 Nov;30(11):1825-33. doi: 10.1093/ndt/gfu371. Epub 2014 Dec 3. Review.

PMID:
25473123
38.

Kidney paired donation: principles, protocols and programs.

Ferrari P, Weimar W, Johnson RJ, Lim WH, Tinckam KJ.

Nephrol Dial Transplant. 2015 Aug;30(8):1276-85. doi: 10.1093/ndt/gfu309. Epub 2014 Oct 7. Review.

PMID:
25294848
39.

Desensitization outcomes: quantifying and questioning.

Cole E, Tinckam KJ.

Am J Transplant. 2014 Jul;14(7):1475-6. doi: 10.1111/ajt.12789. Epub 2014 Jun 9. No abstract available.

40.

A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection.

Sapir-Pichhadze R, Curran SP, John R, Tricco AC, Uleryk E, Laupacis A, Tinckam K, Sis B, Beyene J, Logan AG, Kim SJ.

Kidney Int. 2015 Jan;87(1):182-94. doi: 10.1038/ki.2014.166. Epub 2014 May 14. Review.

41.

The role of donor-specific HLA alloantibodies in liver transplantation.

O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB.

Am J Transplant. 2014 Apr;14(4):779-87. doi: 10.1111/ajt.12667. Epub 2014 Mar 1.

42.

Transplantation: Complementing donor-specific antibody testing.

Tinckam KJ, Heeger PS.

Nat Rev Nephrol. 2013 Dec;9(12):713-4. doi: 10.1038/nrneph.2013.234. Epub 2013 Nov 5.

43.

Angiotensin II Type 1 receptor antibodies: great expectations?

Tinckam K, Campbell P.

Am J Transplant. 2013 Oct;13(10):2515-6. doi: 10.1111/ajt.12396. Epub 2013 Aug 7. No abstract available.

44.

A survey of current practice for antibody-mediated rejection in heart transplantation.

Chih S, Tinckam KJ, Ross HJ.

Am J Transplant. 2013 Apr;13(4):1069-1074. doi: 10.1111/ajt.12162. Epub 2013 Feb 15.

45.

A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients.

Cole EH, Prasad GV, Cardella CJ, Kim JS, Tinckam KJ, Cattran DC, Schiff JR, Landsberg DN, Zaltzman JS, Gill JS.

Transplant Res. 2013 Jan 12;2(1):1. doi: 10.1186/2047-1440-2-1.

46.

Precision diagnostics in transplantation: from bench to bedside.

Mengel M, Campbell P, Gebel H, Randhawa P, Rodriguez ER, Colvin R, Conway J, Hachem R, Halloran PF, Keshavjee S, Nickerson P, Murphey C, O'Leary J, Reeve J, Tinckam K, Reed EF.

Am J Transplant. 2013 Mar;13(3):562-8. doi: 10.1111/j.1600-6143.2012.04344.x. Epub 2012 Dec 27.

47.

Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.

Fairhead T, Hendren E, Tinckam K, Rose C, Sherlock CH, Shi L, Crowcroft NS, Gubbay JB, Landsberg D, Knoll G, Gill J, Kumar D.

Transpl Infect Dis. 2012 Dec;14(6):575-83. doi: 10.1111/tid.12006. Epub 2012 Sep 24.

PMID:
22999005
48.

A sensitive approach.

Chih S, Ross HJ, Tinckam K, McDonald MA, Isaac DL.

J Heart Lung Transplant. 2012 Sep;31(9):1042-3. doi: 10.1016/j.healun.2012.05.015. Epub 2012 Jul 10. No abstract available.

PMID:
22784934
49.

Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.

Noone D, Al-Matrafi J, Tinckam K, Zipfel PF, Herzenberg AM, Thorner PS, Pluthero FG, Kahr WH, Filler G, Hebert D, Harvey E, Licht C.

Am J Transplant. 2012 Sep;12(9):2546-53. doi: 10.1111/j.1600-6143.2012.04124.x. Epub 2012 Jun 8.

50.

Antibody-mediated rejection: an evolving entity in heart transplantation.

Chih S, Chruscinski A, Ross HJ, Tinckam K, Butany J, Rao V.

J Transplant. 2012;2012:210210. doi: 10.1155/2012/210210. Epub 2012 Mar 26.

Supplemental Content

Loading ...
Support Center